Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

Civil society demonstration against IP provisions in RCEP that can block access to affordable medicines. Outside Ministry of Commerce, Udyog Bhawan, New Delhi Photograph by Siddharth Singh
Press release
Press release |
23 February 2017
Intellectual property and trade
Japan

MSF calls on Japan and South Korea to drop the harmful RCEP measures

MSF Pharmacy Technician Toueng Sreymon distributes Hepatitis C meds at the MSF Hepatitis C clinic at Preah Kossamak Hospital in Phnom Penh, Cambodia, 18, April 2017. Photograph by Todd Brown Photograph by Todd Brown
Press release
Press release |
14 February 2017
Hepatitis C

Flawed patents on hepatitis C drugs latest to be challenged in global push for access

6 min
 At the height of the crisis in Yida camp last summer, high mortality rates were reported among young children admitted to MSF’s hospital with respiratory tract infections, such as pneumonia, one of the leading causes of death. 2013 refugee crisis in South Sudan. Photograph by Yann Libessart
Press release
Press release |
07 February 2017
Intellectual property and trade
South Africa

Global day of action against Roche’s inhumanity #RocheGreedKills

12 min
Lab technician Christophe KIKWABANTU at the laboratory of Walikale Hospital, North Kivu, February 12, 2017. Photograph by Gwenn Dubourthoumieu
Press release
Press release |
02 February 2017
Research and development

European public health advocates demand greater public returns from European Commission’s Research and Development Programme, Horizon 2020

3 min
Pooja Iyer, MSF counselor, providing counseling to Hanif, an XDR-TB patient, in the MSF clinic in Mumbai. India 2016 Photograph by Atul Loke/Panos Pictures
Press release
Press release |
30 January 2017
Tuberculosis
India

Health groups call on Government of India to urgently make lifesaving TB drug available

6 min
Medical staff work in the ambulatory ward at the National Centre for Tuberculosis and Lung Disease in Georgia’s capital, Tbilisi. Patient Goderdzi Rajabishvili (left) recovers from his morning infusion of imipenem, an antibiotic drug used for the treatment of MDR-TB. Photograph by Daro Sulakauri Photograph by Daro Sulakauri
Press release
Press release |
25 January 2017

Public Health Groups Welcome Johns Hopkins University and Medicines Patent Pool Agreement

6 min
Nischaya, an XDR-TB patient, looking at her TB medication at the MSF clinic in Mumbai. Photograph by Atul Loke Photograph by Atul Loke
Press release
Press release |
20 January 2017
Tuberculosis

Pioneering new MSF-run clinical trial for drug-resistant TB treatment starts

5 min
MSF staff hold an informative meeting on Chagas treatment in the community of Kochapata, Bolivia. Photograph by Juan Renau Photograph by Juan Renau
Press release
Press release |
20 December 2016
Tropical & neglected diseases

Bolivia: Doctors Without Borders ends Chagas operations, urges Ministry of Health to take over comprehensive care in rural areas

4 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury